Oxford Biomedica Regulatory News (OXB)

26 Jan 2005 11:46

Man Financial Limited26 January 2005 Date Of Disclosure: 26/01/05 Fax to 020 7256 9386 (Take Over Panel) and 020 7588 6057 (RNS) FORM 8.1/8.3 Lodge with a RIS or Newstrack and the Takeover Panel. Use separate form for each class of securities in which dealings have been made. DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3 OF THE CITY CODEON TAKEOVERS AND MERGERS Date of dealing 25/01/05 (1) Name of Company Dealing in OXFORD BIOMEDICA PLC Class of securities ORDINARY SHARES (2) Amount Bought Amount Sold Price (GBP) 1000000 0.2350 500000 0.2250 250000 0.2300 In addition, MAN FIN LTD have entered into CFD arrangements with it's client's which are detailed below. (3) Resultant total of the same class owned or controlled and 19,325,800 5.21% percentage of class (4) Party making disclosure MAN FINANCIAL LIMITED (5) Name of purchaser/vendor (Note1) MAN FINANCIAL LIMITED (6) Reason for disclosure (Note 2) (a) Associate of (i) offeror (Note 3) - NO (b) (i) offeree Company - NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) - YES Signed, for and on behalf of the party named in (4) above Stewart Horner Telephone and extension number 020-7144-4201 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, e.g. where an owner normally acts on instructions of a controller. Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or with an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8. Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that all relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section,Tel. No: 020 7638 0129. E-mail:monitoring@disclosure.org.uk NOTES REGARDING DISCLOSURE MAN FIN Ltd is the beneficial 19,325,800 Ordinary Shares in the above company which are held owner of to hedge CFD positions resulting from CFD contracts (see below) established between MAN FINANCIAL LIMITED and its clients.A Contract for Difference or CFD is an agreement between two parties to exchange, at the close of the contract, the difference between the opening price and the closing price, multiplied by the number of reference shares specified within the contract. The 'reference shares' are the underlying shares specified in the CFD. The economic performance of the CFD is determined by the performance of the underlying reference shares. Although CFDs replicate the price movement of the underlying reference shares,they convey no right or requirement to acquire or deliver the physical shares.The contract value of a CFD is defined as the number of reference shares specified in the contract, multiplied by the price of the underlying reference share. If a client of Man takes a long position, the customer will make a profit if the contract value increases. Conversely, if a customer of Man Financial Ltd takes a short position, the customer will benefit if the contract value falls.The CFD contracts detailed below are open-ended and without predetermined expiry/close value DEFINITION OF ASSOCIATE It is not practicable to define associate in terms which would cover all thedifferent relationships which may exist in an offer. The term associate isintended to cover all persons (whether or not acting in concert) who directly orindirectly own or deal in the shares of an offeror or the offeree company inan offer and who have (in addition to their normal interests as shareholders)an interest or potential interest, whether commercial, financial or personal,in the outcome of the offer Without prejudice to the generality of theforegoing, the term associate will normally include the following:- (1) an offeror's or the offeree company's parent, subsidiaries and fellow subsidiaries, and their associated companies, and companies of which such companies are associated companies (for this purpose ownership or control of 20% or more of the equity share capital of a company is regarded as the test of associated company status); (2) banks and financial and other professional advisers (including stockbrokers)* to an offeror, the offeree company or any company covered in (1), including persons controlling#, controlled by or under the same control as such banks, financial and other professional advisers; (3) the directors (together with their close relatives & related trusts) of an offeror, the offeree company or any company covered in (1); (4) the pension funds of an offeror, the offeree company or any company covered in (1); (5) any investment company, unit trust or other person whose investments an associate manages on a discretionary basis, in respect of the relevant investment accounts; (6) a person who owns or controls 5% or more of any class of relevant securities (as defined in paragraphs (a) to (d) in Note 2 on Rule 8) issued by an offeror or an offeree company, including a person who as a result of any transaction owns or controls 5% or more. When two or more persons act pursuant to an agreement or understanding (formal or informal) to acquire or control such securities, they will be deemed to be a single person for the purpose of this paragraph. Such securities managed on a discretionary basis by an investment management group will, unless otherwise agreed by the Panel, also be deemed to be those of a single person (see Note 8 on Rule 8); and (7) a company having a material trading arrangement with an offeror or the offeree company. Paragraphs (1)-(7) are typical cases. Paragraph (8) below is a category to cover associate status not within (1) -(7). (8) Other. CFD OPEN INTEREST ----------------- No. of Ref PRODUCT NAME EXECUTED MAN FIN LTD Shares PRICE (GBP) ------------ -------- ----------- ----------- ----------- OXFORD BIOMEDICA PLC 25/01/05 SALE 500,000 0.2250 LONG CFD OXFORD BIOMEDICA PLC 25/01/05 SALE 250,000 0.2300 LONG CFD OXFORD BIOMEDICA PLC 25/01/05 SALE 1,000,000 0.2350 LONG CFD OXFORD BIOMEDICA PLC 24/01/05 SALE 100,000 0.2250 LONG CFD OXFORD BIOMEDICA PLC 20/01/05 SALE 75,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 19/01/05 SALE 390,000 0.2275 LONG CFD OXFORD BIOMEDICA PLC 19/01/05 SALE 225,000 0.2345 LONG CFD OXFORD BIOMEDICA PLC 19/01/05 SALE 25,000 0.2250 LONG CFD OXFORD BIOMEDICA PLC 18/01/05 SALE 350,000 0.1896 LONG CFD OXFORD BIOMEDICA PLC 18/11/04 SALE 100,000 0.1788 LONG CFD OXFORD BIOMEDICA PLC 16/11/04 SALE 100,000 0.1850 LONG CFD OXFORD BIOMEDICA PLC 05/11/04 SALE 100,000 0.2088 LONG CFD OXFORD BIOMEDICA PLC 29/10/04 SALE 3,250,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 29/10/04 SALE 100,000 0.1888 LONG CFD OXFORD BIOMEDICA PLC 08/10/04 SALE 100,000 0.2025 LONG CFD OXFORD BIOMEDICA PLC 07/10/04 SALE 200,000 0.2000 LONG CFD OXFORD BIOMEDICA PLC 06/10/04 SALE 25,000 0.1850 LONG CFD OXFORD BIOMEDICA PLC 05/10/04 SALE 550,000 0.1950 LONG CFD OXFORD BIOMEDICA PLC 04/10/04 SALE 250,000 0.1875 LONG CFD OXFORD BIOMEDICA PLC 04/10/04 SALE 30,000 0.1800 LONG CFD OXFORD BIOMEDICA PLC 01/10/04 SALE 500,000 0.1675 LONG CFD OXFORD BIOMEDICA PLC 01/10/04 SALE 250,000 0.1700 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 50,000 0.1675 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 100,000 0.1625 LONG CFD OXFORD BIOMEDICA PLC 30/09/04 SALE 200,000 0.1650 LONG CFD OXFORD BIOMEDICA PLC 29/09/04 SALE 17,200 0.1600 LONG CFD OXFORD BIOMEDICA PLC 17/09/04 SALE 100,000 0.1750 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 200,000 0.1700 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 150,000 0.1650 LONG CFD OXFORD BIOMEDICA PLC 16/09/04 SALE 100,000 0.1540 LONG CFD OXFORD BIOMEDICA PLC 02/09/04 SALE 50,000 0.1600 LONG CFD OXFORD BIOMEDICA PLC 25/08/04 SALE 10,000 0.1450 LONG CFD OXFORD BIOMEDICA PLC 17/08/04 SALE 10,000 0.1525 LONG CFD OXFORD BIOMEDICA PLC 16/08/04 SALE 100,000 0.1550 LONG CFD OXFORD BIOMEDICA PLC 05/07/04 SALE 50,000 0.1965 LONG CFD OXFORD BIOMEDICA PLC 24/06/04 SALE 150,000 0.1950 LONG CFD OXFORD BIOMEDICA PLC 22/06/04 SALE 100,000 0.1900 LONG CFD OXFORD BIOMEDICA PLC 21/06/04 SALE 100,000 0.1900 LONG CFD OXFORD BIOMEDICA PLC 08/06/04 SALE 100,000 0.1995 LONG CFD OXFORD BIOMEDICA PLC 04/06/04 SALE 370,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 04/06/04 SALE 100,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 03/06/04 SALE 25,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 02/06/04 SALE 30,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 28/05/04 SALE 225,000 0.1690 LONG CFD OXFORD BIOMEDICA PLC 13/05/04 SALE 375,000 0.1750 LONG CFD OXFORD BIOMEDICA PLC 23/04/04 SALE 50,000 0.2125 LONG CFD OXFORD BIOMEDICA PLC 13/04/04 SALE 50,000 0.1925 LONG CFD OXFORD BIOMEDICA PLC 08/04/04 SALE 100,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 30/03/04 SALE 100,000 0.2375 LONG CFD OXFORD BIOMEDICA PLC 24/03/04 SALE 250,000 0.2375 LONG CFD OXFORD BIOMEDICA PLC 24/03/04 SALE 2 0.2335 LONG CFD OXFORD BIOMEDICA PLC 22/03/04 SALE 150,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 18/03/04 SALE 50,000 0.2450 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2525 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2438 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 100,000 0.2400 LONG CFD OXFORD BIOMEDICA PLC 11/03/04 SALE 50,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 03/03/04 SALE 200,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 03/03/04 SALE 50,000 0.2675 LONG CFD OXFORD BIOMEDICA PLC 02/03/04 SALE 50,000 0.2900 LONG CFD OXFORD BIOMEDICA PLC 01/03/04 SALE 100,000 0.2840 LONG CFD OXFORD BIOMEDICA PLC 27/02/04 SALE 10,000 0.2800 LONG CFD OXFORD BIOMEDICA PLC 26/02/04 SALE 50,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 26/02/04 SALE 100,000 0.2650 LONG CFD OXFORD BIOMEDICA PLC 23/02/04 SALE 50,000 0.2950 LONG CFD OXFORD BIOMEDICA PLC 23/02/04 SALE 25,000 0.2775 LONG CFD OXFORD BIOMEDICA PLC 19/02/04 SALE 450,000 0.2850 LONG CFD OXFORD BIOMEDICA PLC 18/02/04 SALE 200,000 0.2850 LONG CFD OXFORD BIOMEDICA PLC 17/02/04 SALE 65,000 0.2825 LONG CFD OXFORD BIOMEDICA PLC 12/02/04 SALE 250,000 0.2840 LONG CFD OXFORD BIOMEDICA PLC 11/02/04 SALE 100,000 0.2875 LONG CFD OXFORD BIOMEDICA PLC 11/02/04 SALE 25,000 0.2950 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 100,000 0.2700 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 100,000 0.2575 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 25,000 0.2725 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 450,000 0.2800 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 300,000 0.2712 LONG CFD OXFORD BIOMEDICA PLC 10/02/04 SALE 250,000 0.2750 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 350,000 0.2668 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 150,000 0.2500 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 100,000 0.2625 LONG CFD OXFORD BIOMEDICA PLC 06/02/04 SALE 25,000 0.2650 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 750,000 0.2350 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 50,000 0.2630 LONG CFD OXFORD BIOMEDICA PLC 05/02/04 SALE 25,000 0.2600 LONG CFD OXFORD BIOMEDICA PLC 04/02/04 SALE 158,000 0.2475 LONG CFD OXFORD BIOMEDICA PLC 02/02/04 SALE 25,000 0.2550 LONG CFD OXFORD BIOMEDICA PLC 23/01/04 SALE 100,000 0.2750 LONG CFD OXFORD BIOMEDICA PLC 22/01/04 SALE 20,000 0.2640 LONG CFD OXFORD BIOMEDICA PLC 21/01/04 SALE 250,000 0.2600 LONG CFD OXFORD BIOMEDICA PLC 21/01/04 SALE 200,000 0.2538 LONG CFD OXFORD BIOMEDICA PLC 08/01/04 SALE 50,000 0.2100 LONG CFD OXFORD BIOMEDICA PLC 17/12/03 SALE 67,609 0.2200 LONG CFD OXFORD BIOMEDICA PLC 11/12/03 SALE 500,000 0.2050 LONG CFD OXFORD BIOMEDICA PLC 10/12/03 SALE 600,000 0.2033 LONG CFD OXFORD BIOMEDICA PLC 03/12/03 SALE 600,000 0.1975 LONG CFD OXFORD BIOMEDICA PLC 27/11/03 SALE 72,989 0.1900 LONG CFD This information is provided by RNS The company news service from the London Stock Exchange